Results 161 to 170 of about 137,036 (264)

Metabolic Risk Factors Are Associated With Weight Status Change Over Four Years in Children Aged 4–6 Years With Obesity

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim It is unclear how early childhood obesity treatment affects metabolic risk. This study assessed long‐term metabolic health in children with obesity aged 4–6 years and examined associations with weight status. Methods This prospective cohort study pooled data from the Sweden‐based More and Less randomized controlled trial, which compared a ...
Markus Brissman   +6 more
wiley   +1 more source

The Prevalence and Risk Factors for at‐Risk MASH and Advanced Liver Fibrosis in People With Metabolic Risk Factors in Primary Care

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
This cross‐sectional study of 84 general practices found 24.3% had At‐Risk MASH defined by FNI > 0.30, and 4.3% had advanced fibrosis defined by FIB‐4 > 2.67. Diabetes and socio‐economic disadvantage were strong predictors of significant liver disease.
Leon A. Adams   +7 more
wiley   +1 more source

Various dimensions of sexual self‐concept in middle‐aged men after vasectomy: a matched analysis

open access: yesBJU International, EarlyView.
Objectives To compare men with and without vasectomy across four dimensions of sexual self‐concept—toughness, body image, sexual self‐esteem, and perceived pressure with regard to sexuality—and to examine differences in sexual behaviour and psychosocial factors.
Lilly J. Schmalbrock   +9 more
wiley   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

open access: yesBritish Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli   +7 more
wiley   +1 more source

Re‐thinking peripheral dysfunctions in obesity: The emerging role of sulphaceutics and sulphanutraceutics

open access: yesBritish Journal of Pharmacology, EarlyView.
Obesity is a chronic, relapsing, multisystem disease in which cardiometabolic risk arises from excess adiposity and progressive dysfunction of peripheral organs, ultimately disrupting endocrine and metabolic crosstalk among tissues. Within this network, sulphur‐based biology, centred on hydrogen sulphide and related reactive sulphur species, has ...
Martina Smimmo   +4 more
wiley   +1 more source

Oral Health Interventions for People Living With Diabetes From a Public Health Perspective: A Mapping Review

open access: yesCommunity Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives Despite growing concerns about the oral health‐diabetes link, there is a lack of dental health interventions focused on people with diabetes. This mapping review synthesised the current landscape of oral health interventions for people with diabetes and identified future opportunities.
Fernando Valentim Bitencourt   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy